Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Industry News

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

November 14, 2017

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Daily News

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Yael L. Maxwell

April 10, 2014

News Daily News

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

L.A. McKeown

August 19, 2013

News Daily News

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

Caitlin E. Cox

February 09, 2012

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

Advertisement

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content